Disposal of Key2Futures to Horizon



Disposal of Key2Futures to Horizon HMT, led by Partner Ian Barton and with tax advice from Holly Bedford-Bell have advised the shareholders of specialist care and support business Key2 Futures Ltd (“Key2”) on the disposal of the business to Horizon Care and Education Group (“Horizon”). Key2 was set up in 2004 to meet the needs of young people leaving local authority care with complex and high support needs. Since then, Key2 have diversified to offer a range of services [...]

Investment in ADC Biotechnology by Maven

, ,


Maven invests in ADC Biotechnology HMT, led by Partner Paul Read advised Maven Capital Partners (“Maven”) on their investment in anti-cancer drugs manufacturer ADC Biotechnology (“ADC”). ADC Bio operates in the highest growth sector within oncology therapeutics and has developed a unique patented Lock-Release technology for the development and manufacture of Antibody Drug Conjugates (ADC) group of cancer therapies which are designed to specifically target and kill tumour cells. Known as ‘magic bullets’, ADCs are the next generation of [...]

Disposal of Foresight Partnership Ltd

, ,


Disposal of Foresight Partnership Ltd HMT LLP, led by partner Andrew Thomson, director Holly Bedford and senior manager Matthew Gordon-Smith, advised the shareholders of Foresight Partnership Limited, one of the leading niche governance and organisational development consultancies in healthcare in the UK, on their disposal to GE Healthcare Finnamore. The acquisition will see the launch of the 'Foresight Centre for Governance' at GE Healthcare Finnamore, adding to GE Healthcare Finnamore's specialist health and social care consultancy base.  The Centre will [...]

Investment in Disposal Cubicle Curtains Limited by Beringea

, ,


HMT advised Beringea LLP (“Beringea”),  the growth capital investor that manages the Proven Venture Capital Trusts, on their £3 million investment in Disposable Cubicle Curtains Limited (“DCCL”), trading as All in One Medical. DCCL manufactures and distributes an evolving range of patented, best in class, disposable curtains and blinds which actively destroy deadly and harmful pathogens.  Distributed to medical institutions, DCCL’s products are manufactured and shipped from its manufacturing plant in Wolverhampton, UK. Part of Beringea’s investment was [...]

Disposal of Basan UK Limited



HMT advised Cleanroom Products (Holdings) Limited on the disposal of Basan UK Limited ("Basan"), a leading supplier of cleanroom consumables and equipment for the pharmaceutical, medical, engineering and food industries, to VWR International LLC ("VWR"), a supplier and distributor of scientific supplies to the research laboratory market. Basan, based in Basingstoke, Hampshire, is the UK's largest specialist cleanroom distributor, with 25 years in the cleanroom market and a client base spanning across the pharmaceutical, medical device, biotechnology, microelectronics, [...]

Disposal of Netmums Ltd



HMT, led by partner Andrew Thomson, advised the shareholders of Netmums Limited on the disposal to the Aufeminin Group, the No.1 publisher of women’s websites worldwide. HMT led a competitive sale process which resulted in realising maximum value for the shareholders. Established in 2000, London based Netmums.com is a parental website “designed for mums by mums” with its main features being editorial content, discussion forums and chats. The website operates on the basis of contributions from its users [...]

Disposal of EcoTECH

, ,


HMT, led by partner Andrew Thomson, advised the shareholders of ecoTECH on their disposal to Climate Energy Limited, a leading carbon reduction management agent. Founded by Christine Hynes and David Alderton, Ecotech designs and builds ecoTECH ZCBS, a UK Zero Carbon off-site manufactured complete building envelope, which complies with the UK‘s new Governments building regulations. ecoTECH ZCBS is leading the market with a cost on par with that of traditional build and a capacity to deliver up to [...]

Imperial Innovations Group PLC Invests in Stanmore Implants

, ,


    HMT advised Imperial Innovations, the UK's leading technology commercialisation and investment company, on its £4 million investment in Stanmore Implants. Stanmore Implants is a specialist in the design and manufacture of patient specific implants for complex orthopaedic reconstructions. Stamnore currently focuses on orthopaedic oncology, and complex primary and secondary revisions in the upper limb, lower limb and pelvis, with a custom design and manufacture service. The proceeds will be used to expand Stanmore's US and UK [...]

Disposal of in4tek Limited to Civica Group Ltd



HMT advised the shareholders of in4tek Limited on its disposal to Civica Group Ltd. in4tek, based in Altrincham, specialises in application software and related services for the health and social care sectors. Its integrated product suite, which enables the management of all aspects of community-based care, is used by health service providers and local authorities across the UK and Canada, including within Connecting for Health, the NHS National Programme for IT in England. The company was owned by [...]

Wound Solutions completes round of fundraising



Wound Solutions Limited, exclusively advised by HMT, have successfully raised £2.5m in development funding from both new and existing investors. This will enable Wound Solutions to bring to market its initial product. Wound Solutions is involved in developing an innovative solution for the healing of chronic wounds by combining the benefits of electrotherapy with the ability for continuous monitoring. Initial studies have shown strong potential for Wound Solutions' first product and it is already in the midst of [...]

Acquisition by Premier Research Arizona LLC of Pivotal Research Centers Inc

, ,


  HMT advised Premier Research Group (“PRG”), an international pharmaceutical services group, on the acquisition of Pivotal Research Centers Inc (“Pivotal”), funded by ECI Partners. The acquisition continues PRG’s buy and build growth strategy to build a leading international contract research organisation, whilst also complimenting PRG’s existing offering in the market. Pivotal is well established as a clinical research business based in Phoenix Arizona, with two further sites in Mesa and Salt Lake City. Today the business has [...]

Acquisition of Healthcare Software Systems Limited

, , ,


HMT acted as reporting accountants for Sunset Dawn Limited on its acquisition of Healthcare Software Systems Limited. HSS was established in 1987 and is now a leading provider of radiology information management solutions in the healthcare industry.  This has been brought about by the development and supply of specialist software, namely ‘Computerised Radiology Information System’ (“CRIS”) under the National Programme for IT launched by the National Health Service in 2002. CRIS has now been embedded into around 150 [...]

Premier Research plc acquired Scirex Corporation Group for up to £20 million



HMT advised Premier Research Group plc (“PRG”), an international pharmaceutical services group, on the acquisition of the Scirex Corporation Group (“Scirex”) for up to £20 million. Scirex, a subsidiary of Omnicom Inc, the global leader in marketing communications, is a full service contract research organisation (“CRO”) specialising in providing outsourced clinical services to a number of pharmaceutical areas. It specialises in trials from Phase I through to Phase IV, specialising in analgesia (CNS), general medicine (e.g. cardiovascular) and [...]

Acquisition of Apollo Medical Systems Limited

, , ,


  I HMT acted as reporting accountants for Sunset Dawn Limited on its acquisition of Apollo Medical Systems Limited (“Apollo”). Apollo was established in 2000 and is now a well-established and successful provider of IT solution to the National Health Service (“NHS”). This has been brought about by the development and supply of specialist software, SQL suite, which has now effectively been embedded into around 90% of GP surgeries. HMT commented: “We consider that in light of the [...]

Premier Research Plc acquired PharmData Inc for up to £12.0 million and Imform GmbH for up to £4.5 million



HMT advised Premier Research Group plc (“PRG”) an international pharmaceutical services group on the acquisition of Pharmdata Inc (“PharmData”) and Imform GmbH (“Imform”) for up to £12.0 million and £4.5 million respectively. PharmData is a Contract Research Organisation (“CRO”) that specialises in clinical data management, statistical analysis, medical writing, electronic archiving and project management services for the pharmaceutical, biotechnology, and medical device industries.  The business, which was set up in 1994, is based in Atlanta, USA and employs [...]

Premier Research Plc acquired EPA Euro Pharma GmbH for £3.2 million



HMT advised Premier Research Group Plc (“PRG”) an international pharmaceutical services group on the acquisition of EPA Euro Pharma GmbH (“EPA”) for £3.2 million. EPA is a contract research organisation (“CRO”), based near Frankfurt, providing a broad range of outsourced clinical services to the biotechnology and pharmaceutical industries. The majority of EPA orders are with German pharmaceutical and biotechnology companies. However, EPA also has contracts with several of the world’s largest multinational pharmaceutical groups. Dr Simon Yaxley, Chief [...]

Initial Public Offering of Premier Research Group



HMT advised and acted as reporting accountants to Premier Research Group on the AIM flotation in December 2004. The flotation raised £8 million before costs at a placing price of 40p per share, and was accompanied by the raising of a £3.5 million banking facility from Lloyds TSB. This enabled Premier Research Group to repay its Acquisition Loans and strengthen its balance sheet. Premier Research Group was originally established in 2002 as a buy and build strategy, with [...]

Refinancing of Advanced Clinical Sciences Corporation Ltd and acquisition of CRC GmbH (Switzerland) and CRC SRL (Italy)

, , ,


HMT advised its client Advanced Clinical Research Corporation Limited (“ACSC”) in the refinancing of its growing operations and the acquisition of the pan European CRC Group. ACSC was founded in 2002 by Dr Guy Patrick, Dr Simon Yaxley and Mr Tim Carden, all of whom have extensive experience of the pharmaceutical industry. The objective of the business was to build a contract Clinical Research Organisation (“CRO”) with a global footprint in the medical clinical research market through buy [...]

Management buyout RBF Group



HMT advised the management team in its buyout of RBF Group, the Southend on Sea based manufacturer of healthcare products and heatshields, having been recommended to management by Northern Venture Managers.  RBF Group has premises in Southend on Sea, Salford and Cambridge. The business operates in three distinct markets, manufacturing healthcare products for private consumers and the social services, heat shields for use on engine and exhaust systems, and third party manufacturing projects such as seat covers and [...]